REQUEST A DEMO
Total
USD $0.00
Search more companies

Sapolab CIA Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sapolab CIA Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Sapolab CIA Ltda is an enterprise based in Ecuador. Its main office is in Quito. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on November 24, 2008. It currently has a total number of 4 (2023) employees. In 2023, the company reported a net sales revenue increase of 48.69%. There was a total growth of 47.02% in Sapolab CIA Ltda’s total assets over the same period. The enterprise’s net profit margin decreased by 8.86% in 2023.

Headquarters
Guanguiltagua N39-66
Quito; Pichincha;

Contact Details: Purchase the Sapolab CIA Ltda report to view the information.

Website: http://www.sapolabec.com

Basic Information
Total Employees:
Purchase the Sapolab CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Sapolab CIA Ltda report to view the information.
Registered Capital:
Purchase the Sapolab CIA Ltda report to view the information.
Incorporation Date:
November 24, 2008
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
95%
Purchase this report to view the information.
5%
Company Performance
Financial values in the chart are available after Sapolab CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
48.69%
Total operating revenue
48.69%
Net Profit (Loss) for the Period
-70.48%
Total assets
47.02%
Total equity
2.6%
Net Profit Margin
-8.86%
Return on Equity (ROE)
-6.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?